A61K 31/136
Having the amino group directly attached to the aromatic ring
Official title: having the amino group directly attached to the aromatic ring, e.g. benzeneamine
A61K31/136 (Having the amino group directly attached to the aromatic ring) appears on 599 US grants and 1,159 published applications in this corpus.
Search patents in A61K- Granted patents
- 599
- Published applications
- 1,159
- Assignees
- 619
- Inventors
- 2,266
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 15 | 0 |
| 2000 | 11 | 0 |
| 2001 | 6 | 5 |
| 2002 | 11 | 22 |
| 2003 | 11 | 25 |
| 2004 | 4 | 28 |
| 2005 | 9 | 26 |
| 2006 | 7 | 22 |
| 2007 | 8 | 19 |
| 2008 | 5 | 30 |
| 2009 | 3 | 36 |
| 2010 | 12 | 38 |
| 2011 | 7 | 33 |
| 2012 | 22 | 44 |
| 2013 | 24 | 44 |
| 2014 | 26 | 72 |
| 2015 | 21 | 70 |
| 2016 | 44 | 67 |
| 2017 | 45 | 73 |
| 2018 | 38 | 48 |
| 2019 | 40 | 61 |
| 2020 | 30 | 70 |
| 2021 | 37 | 62 |
| 2022 | 38 | 68 |
| 2023 | 35 | 55 |
| 2024 | 19 | 69 |
| 2025 | 29 | 33 |
| 2026 | 26 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of initiating sotalol hydrochloride dosing22 Sep 2026US 12,740,947 B2AltaThera Pharmaceuticals LLC
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Anti-CK8 antibody and exosome compositions, methods of making, and methods of treating25 Aug 2026US 12,714,749 B2Peak Way Group Inc.
- Methods for treating nasal polyposis by administering an IL-4R antagonist18 Aug 2026US 12,709,642 B2Regeneron Pharmaceuticals, Inc.
- Focal adhesion kinase inhibitor as a therapeutic agent in diabetes11 Aug 2026US 12,702,667 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Modified liposome for drug delivery, use of liposome for drug delivery, especially with anti-cancer activity, and ways to load liposome with drugs, especially with anti-cancer activity8 Oct 2026US 2026/0306403 A1Bs Biotechna Spolka Akcyjna
- Combination therapy for treatment of depression8 Oct 2026US 2026/0306839 A1Flow Neuroscience, Inc.
- Indole lactate for the treatment of multiple sclerosis1 Oct 2026US 2026/0294870 A1The Johns Hopkins University
- Methods for decreasing neuronal death, inflammation, and degeneration1 Oct 2026US 2026/0297571 A1The Johns Hopkins University
- Ferroptosis inhibitors24 Sep 2026US 2026/0283988 A1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Most cited
By later US patents
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Anti-angiogenic compositions and methods of use413US 5,886,026 AAngiotech Pharmaceuticals, Inc. · 1999
- Anti-angiogenic compositions and methods of use242US 6,544,544 B2Angiotech Pharmaceuticals, Inc. · 2003
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Anti-angiogenic compositions and methods of use150US 6,506,411 B2Angiotech Pharmaceuticals, Inc. · 2003